Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner - 30/11/11
Abstract |
Background |
Oral exposure to food allergens may be limited in infancy, and the initial site of antigen exposure likely plays an important role in food allergy induction.
Objective |
To examine the impact of different routes of exposure by using milk allergens, with and without adjuvant, on sensitization.
Methods |
C3H/HeJ mice were repeatedly exposed to the milk allergen ⍺-lactalbumin (ALA), with or without cholera toxin (CT). Sensitization routes used were intragastric, cutaneous, intranasal, and sublingual. Anaphylaxis severity was assessed by symptoms and body temperature in response to oral challenge. Antigen-specific serum antibodies were measured by ELISA. The mechanism of adjuvant activity of cutaneous CT was also determined.
Results |
Sensitization to ALA as measured by allergen-specific IgE occurred by all routes of sensitization and was maximal in response to cutaneous exposure. Sensitization was dependent on CT and did not occur to antigen alone by any route. Mucosal, but not cutaneous, exposure resulted in a robust allergen-specific IgA response. Anaphylaxis occurred in all sensitized groups when orally challenged with ALA. Topical CT induced migration of langerinneg dermal dendritic cells to the lymph node, resulting in enhanced proliferation and TH2 cytokine production from responder T cells.
Conclusions |
Sensitization can occur via all physiologic routes when adjuvant is present. The skin is a potent and likely important physiologic route of sensitization whereby adjuvant induces an efflux of antigen-bearing dermal dendritic cells to the lymph node that generate a proallergic TH2 response.
Le texte complet de cet article est disponible en PDF.Key words : Adjuvant, dendritic cell, milk allergy, mucosal, tolerance
Abbreviations used : ALA, CFSE, CT, DC, OVA, SEB, SLN, TLR
Plan
This work was supported by NIH grants PO1 AI044236 and K12 HD052890. |
|
Disclosure of potential conflict of interest: M. C. Berin receives research support from the National Institutes of Health (NIAID). The rest of the authors have declared that they have no conflict of interest. |
Vol 128 - N° 6
P. 1251 - décembre 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?